Not applicableApproved For MarketingNCT05722912
What this trial is testing
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Showing 20 of 0 results